Nanion Corporate Blog

 

12.05.2017: New Application Note on TREK-1 is out!

 

The latest Application Note from Nanion shows recordings of TREK-1 on the SyncroPatch 384PE.

 

HEK cells expressing TREK-1 (an excellent cell line from SB Drug Discovery) were used on the SyncroPatch 384PE with a high success rate and BL-1249 and THA were used to activate and inhibit TREK-1, respectively. Read the full allpication note here.

 

Back to Overview

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok